Adverse events492

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 492

Type	Event	Organ system	Group	Affected	At risk	Events
other	Flushing	Vascular disorders	BEGEDINA® (Begelomab)	0	18	0
other	Flushing	Vascular disorders	Conventional Second-line Treatment	1	18	1
other	Hypertension	Vascular disorders	BEGEDINA® (Begelomab)	2	18	2
other	Hypertension	Vascular disorders	Conventional Second-line Treatment	3	18	3
other	Hypotension	Vascular disorders	BEGEDINA® (Begelomab)	3	18	3
other	Hypotension	Vascular disorders	Conventional Second-line Treatment	4	18	4
other	Shock	Vascular disorders	BEGEDINA® (Begelomab)	1	18	1
other	Shock	Vascular disorders	Conventional Second-line Treatment	0	18	0
other	Deep vein thrombosis	Vascular disorders	BEGEDINA® (Begelomab)	1	18	1
other	Deep vein thrombosis	Vascular disorders	Conventional Second-line Treatment	1	18	1
other	Superior vena cava occlusion	Vascular disorders	BEGEDINA® (Begelomab)	1	18	1
other	Superior vena cava occlusion	Vascular disorders	Conventional Second-line Treatment	0	18	0
other	Transurethral bladder resection	Surgical and medical procedures	BEGEDINA® (Begelomab)	0	18	0
other	Transurethral bladder resection	Surgical and medical procedures	Conventional Second-line Treatment	1	18	1
other	Hypogammaglobulinaemia	Immune system disorders	BEGEDINA® (Begelomab)	1	18	1
other	Hypogammaglobulinaemia	Immune system disorders	Conventional Second-line Treatment	1	18	1
other	Graft versus host disease in gastrointestinal tract	Immune system disorders	BEGEDINA® (Begelomab)	2	18	2
other	Graft versus host disease in gastrointestinal tract	Immune system disorders	Conventional Second-line Treatment	0	18	0
other	Graft versus host disease in liver	Immune system disorders	BEGEDINA® (Begelomab)	2	18	2
other	Graft versus host disease in liver	Immune system disorders	Conventional Second-line Treatment	0	18	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02411084/events

API reference For AI assistants

Adverse events492

Sources 3

Read this list from software.